DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 148 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $13,490,000 | -44.8% | 396,977 | -40.5% | 0.02% | -36.1% |
| Q2 2021 | $24,426,000 | -18.8% | 667,177 | -0.6% | 0.04% | -20.0% |
| Q1 2021 | $30,086,000 | -21.4% | 670,975 | 0.0% | 0.04% | -27.4% |
| Q4 2020 | $38,293,000 | +11.2% | 670,975 | 0.0% | 0.06% | -3.1% |
| Q3 2020 | $34,421,000 | -14.1% | 670,975 | 0.0% | 0.06% | -36.6% |
| Q2 2020 | $40,071,000 | +70.5% | 670,975 | +17.5% | 0.10% | +1.0% |
| Q1 2020 | $23,507,000 | -10.5% | 570,975 | +35.3% | 0.10% | +2.0% |
| Q4 2019 | $26,267,000 | -9.3% | 422,035 | -50.6% | 0.10% | -3.9% |
| Q3 2019 | $28,969,000 | +96.6% | 853,547 | +30.6% | 0.10% | +75.9% |
| Q2 2019 | $14,737,000 | -2.8% | 653,547 | 0.0% | 0.06% | -23.7% |
| Q1 2019 | $15,169,000 | +44.9% | 653,547 | +31.1% | 0.08% | +11.8% |
| Q4 2018 | $10,465,000 | -27.9% | 498,547 | +32.9% | 0.07% | -1.4% |
| Q3 2018 | $14,520,000 | – | 375,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |